Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults

NCT02599896 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

NIH

Sponsor class

Conditions

Prevention of HIV Infection
HIV Antibodies
Monoclonal Antibody, Human
Neutralizing Antibody

Interventions

BIOLOGICAL: VRC-HIVMAB080-00-AB (VRC01LS)
BIOLOGICAL: VRC-HIVMAB060-00-AB (VRC01)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)